MeSH term
Frequency | Condition_Probility | Adult | 14 | 0.0 |
Animals | 27 | 0.0 |
Child | 10 | 0.0 |
Female | 39 | 0.0 |
Humans | 65 | 0.0 |
Research Support, Non-U.S. Gov't | 43 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Blotting, Northern | 3 | 0.0 |
*Chromosomes, Human, Pair 15 | 7 | 3.0 |
Fibroblasts | 2 | 0.0 |
Gene Expression | 7 | 0.0 |
*Genomic Imprinting | 10 | 3.0 |
In Situ Hybridization, Fluorescence | 6 | 0.0 |
Ligases/*genetics | 22 | 21.0 |
Male | 36 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 38 | 0.0 |
Ribonucleoproteins, Small Nuclear/genetics | 4 | 28.0 |
Ubiquitin-Protein Ligases | 34 | 16.0 |
Chromosome Mapping | 12 | 0.0 |
*Membrane Transport Proteins | 3 | 0.0 |
Microsatellite Repeats | 7 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Sequence Deletion | 4 | 0.0 |
Alleles | 9 | 0.0 |
Blotting, Southern | 6 | 0.0 |
Brain/metabolism | 5 | 0.0 |
Chromosome Aberrations | 2 | 0.0 |
Chromosomes, Human, Pair 15/genetics | 9 | 13.0 |
DNA Methylation | 9 | 1.0 |
Mutation | 8 | 0.0 |
Pedigree | 12 | 0.0 |
Autoantigens/genetics | 2 | 5.0 |
Genomic Imprinting/*genetics | 12 | 15.0 |
Mice | 22 | 0.0 |
RNA/genetics | 2 | 1.0 |
*Ribonucleoproteins, Small Nuclear | 3 | 5.0 |
Adenosinetriphosphatase/*genetics | 2 | 2.0 |
Autistic Disorder/*genetics | 5 | 8.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Child, Preschool | 11 | 0.0 |
DNA/chemistry/genetics | 2 | 0.0 |
DNA Mutational Analysis | 10 | 0.0 |
Genotype | 8 | 0.0 |
*Linkage Disequilibrium | 3 | 1.0 |
Polymorphism, Single Nucleotide | 3 | 0.0 |
Chromosomes, Human, Pair 15/*genetics | 6 | 6.0 |
Genomic Imprinting/genetics | 4 | 23.0 |
Mutation/*genetics | 3 | 0.0 |
Phenotype | 11 | 0.0 |
Polymorphism, Genetic/genetics | 3 | 0.0 |
Angelman Syndrome/genetics | 3 | 23.0 |
Autoantigens/*genetics | 2 | 2.0 |
Base Sequence | 14 | 0.0 |
Exons | 4 | 0.0 |
Gene Dosage | 3 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Introns | 3 | 0.0 |
Molecular Sequence Data | 18 | 0.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
Prader-Willi Syndrome/genetics | 6 | 28.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Angelman Syndrome/*genetics | 21 | 42.0 |
Chromosomes, Human, Pair 15 | 11 | 8.0 |
Prader-Willi Syndrome/*genetics | 9 | 11.0 |
DNA, Complementary/*genetics | 2 | 0.0 |
Embryonic Development/*genetics | 2 | 18.0 |
Gene Amplification | 2 | 0.0 |
Gene Expression Regulation, Developmental/*genetics | 2 | 2.0 |
Oocytes/*physiology | 2 | 5.0 |
Pregnancy | 3 | 0.0 |
Chromosome Deletion | 4 | 0.0 |
Gene Frequency | 3 | 0.0 |
Receptors, GABA-A/genetics | 3 | 23.0 |
Case-Control Studies | 3 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Comparative Study | 9 | 0.0 |
Adolescent | 6 | 0.0 |
Linkage (Genetics)/genetics | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
*Gene Deletion | 6 | 0.0 |
Ligases/genetics | 7 | 18.0 |
Receptors, GABA-A/*genetics | 4 | 5.0 |
Disease Models, Animal | 4 | 0.0 |
Gene Deletion | 2 | 0.0 |
*Mutation | 9 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Angelman Syndrome/*enzymology/*genetics | 2 | 100.0 |
Ligases/biosynthesis/*genetics | 3 | 75.0 |
Organ Specificity | 3 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
Brain/*metabolism | 3 | 0.0 |
Mice/*genetics | 2 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Ubiquitin-Protein Ligases/*genetics | 7 | 20.0 |
Electroencephalography | 2 | 0.0 |
Genomic Imprinting | 10 | 5.0 |
*Disease Models, Animal | 2 | 0.0 |
Mosaicism | 2 | 2.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Genetic Markers | 3 | 0.0 |
Haplotypes | 3 | 0.0 |
Translocation, Genetic | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Paternity | 2 | 2.0 |
Cloning, Molecular | 2 | 0.0 |
Mice, Mutant Strains | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Frameshift Mutation | 2 | 0.0 |
Ubiquitins/metabolism | 3 | 2.0 |
Cell Line | 2 | 0.0 |
Angelman Syndrome/genetics/*metabolism | 2 | 100.0 |
DNA Primers | 3 | 0.0 |
Oligonucleotide Array Sequence Analysis/*methods | 2 | 1.0 |
Uniparental Disomy/*genetics | 2 | 20.0 |
*Repressor Proteins | 2 | 0.0 |
Genetic Counseling/methods | 2 | 33.0 |
*Sequence Deletion | 2 | 0.0 |
